200,000+ products from a single source!
sales@angenechem.com
Home > Nitro Compounds > 116496-76-5
116496-76-5 | Acetamide, N-(2-ethoxy-4-nitrophenyl)-
CAS No: 116496-76-5 Catalog No: AG000CMH MDL No:MFCD00994990
Product Description
Catalog Number:
AG000CMH
Chemical Name:
Acetamide, N-(2-ethoxy-4-nitrophenyl)-
CAS Number:
116496-76-5
Molecular Formula:
C10H12N2O4
Molecular Weight:
224.2133
MDL Number:
MFCD00994990
IUPAC Name:
N-(2-ethoxy-4-nitrophenyl)acetamide
InChI:
InChI=1S/C10H12N2O4/c1-3-16-10-6-8(12(14)15)4-5-9(10)11-7(2)13/h4-6H,3H2,1-2H3,(H,11,13)
InChI Key:
XZWVZJDHIDYKPB-UHFFFAOYSA-N
SMILES:
CCOc1cc(ccc1NC(=O)C)[N+](=O)[O-]
EC Number:
601-432-8
Properties
Complexity:
264
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
224.08g/mol
Formal Charge:
0
Heavy Atom Count:
16
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
224.216g/mol
Monoisotopic Mass:
224.08g/mol
Rotatable Bond Count:
3
Topological Polar Surface Area:
84.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.5
Literature
| Title | Journal |
|---|---|
| Sotatercept, a soluble activin receptor type 2A IgG-Fc fusion protein for the treatment of anemia and bone loss. | Current opinion in molecular therapeutics 20101001 |
| A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys. | Bone 20100401 |
| Single-dose, randomized, double-blind, placebo-controlled study of ACE-011 (ActRIIA-IgG1) in postmenopausal women. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090401 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.